Final hours! Save up to 55% OFF InvestingProCLAIM SALE

Harvard professor didn't lie about China ties, lawyer says at U.S. trial

Published 12/15/2021, 01:00 PM
Updated 12/15/2021, 01:08 PM
© Reuters. FILE PHOTO: Harvard University nanotechnology professor Charles Lieber, who is charged with lying to U.S. authorities about his ties to a China-run recruitment program and funding he allegedly received from the Chinese government for research, arrives at

By Nate Raymond

BOSTON (Reuters) - A lawyer for a Harvard University professor charged with concealing his ties to a China-run recruitment program accused U.S. prosecutors on Wednesday of "inventing something out of nothing" as the closely watched trial got underway.

Jurors heard opening statements from prosecution and defense lawyers in the trial of Charles Lieber, a nanotechnology pioneer and former Harvard chemistry department chairman facing six criminal charges including making false statements, filing false tax returns and failing to report foreign bank accounts.

Lieber, 62, stood briefly to face the jury in federal court in Boston as defense lawyer Marc Mukasey said investigators "mangled" or "made up" evidence to try to show that the defendant lied to authorities.

"If there was a Nobel Prize for inventing something out of nothing, the government's case would win," Mukasey told jurors.

In the prosecution opening statement, Assistant U.S. Attorney James Drabick told jurors that Lieber was a participant in China's Thousand Talents Program, which prosecutors have said China uses to entice foreign researchers to share their knowledge with it.

The trial represents a test of the U.S. Justice Department's "China Initiative" launched in 2018 to combat Chinese economic espionage and trade secrets theft. Critics have said the initiative harms academic research and racially profiles Chinese researchers.

Drabick said Lieber participated in the Thousand Talents Program by affiliating from 2011 to 2015 with Wuhan University of Technology in China, which paid him tens of thousands of dollars in hopes of boosting its own reputation.

Lieber denied his involvement in response to inquiries from the U.S. Defense Department and the U.S. National Institutes of Health, which had awarded him $15 million in research grants, and concealed his income and a Chinese bank account, Drabick said.

Drabick said Lieber's emails prove that he participated in the program and that, after his 2020 arrest, he admitted in a recorded FBI interview that he "shouldn't have had an agreement and accepted money."

© Reuters. FILE PHOTO: Harvard University nanotechnology professor Charles Lieber, who is charged with lying to U.S. authorities about his ties to a China-run recruitment program and funding he allegedly received from the Chinese government for research, arrives at the federal courthouse in Boston, Massachusetts, U.S., December 14, 2021.   REUTERS/Brian Snyder/File Photo

"You'll hear him explain he did so when he was younger and stupid," Drabick said.

Defense lawyer Mukasey said that investigators failed to write down exactly what Lieber told them prior to his arrest and that he had tried to respond truthfully during "confused" questioning by the FBI after his arrest.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.